Greenphire Partners with ERT to Boost Patient Compliance for Global Clinical Trials

PHILADELPHIA, April 9, 2014 /PRNewswire/ -- Greenphire, the leading provider of payment technology for the clinical trial industry, today announced the launch of a strategic partnership with ERT, a global leader in high-quality patient safety and efficacy endpoint data collection. The partnership will integrate Greenphire's ClinCard System with ERT's best-in-class electronic patient reported outcomes (ePRO) technology.

"By incorporating our ClinCard technology with ERT's remote collection of ePRO assessments we are able to enhance the value of our technologies to our joint clients," said Kyle Cunningham, Vice President of Product Management for Greenphire. "We know how vital accurate subject self-report data is to a clinical trial. By linking patient reporting to compensation, our clients can now enhance patient engagement between site visits and, consequently, improve compliance."

This partnership will enable sponsors and CROs to offer real-time compensation to patients for compliance with study protocols by linking their ePRO activity to a ClinCard personal debit card. Now, in addition to using Greenphire's system to compensate participants with stipends for site visits, clients can customize out-of-office reimbursement for patients' time and effort based on the specific requirements of each protocol.

"This partnership is the next step forward in maximizing patient compliance," commented Jim Corrigan, Executive Vice President and Chief Operating Officer, ERT. "Patients are a trial's most valuable asset and by combining ERT and Greenphire's technology, sponsors and CROs will be able to have a simple, reliable communication link to patients as well as a seamless tool for reimbursing them for their time and expense."

Sam Whitaker, co-founder and CEO of Greenphire added, "We are thrilled to be working with ERT on this game-changing partnership. ERT has built and deployed more than 100,000 ePRO devices through more than 100 international trials. Their track record speaks for itself and we look forward to providing this combined technology solution to help increase compliance, speed time-to-market, and boost return on investment for our clients who are developing life-saving treatments to meet global health needs."

For further information on Greenphire and its innovative solutions please email: [email protected] or visit www.greenphire.com.

About ERT

ERT (www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increases the accuracy and reliability of patient data and improves the efficiency of the clinical development process throughout the product lifecycle.

ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COA) – which includes patient, clinician, and observer reported outcomes. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes, and delivers safety and efficacy data critical to the approval, labeling, and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Japan, and Germany.

About Greenphire

Greenphire is the industry's leading provider of clinical payment technology, designed to change the way research professionals work. We leverage our proprietary workflow automation and advanced web‐based payment technologies to help our clients improve operational efficiency, access clinical financial analytics, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning. Learn more at www.greenphire.com.

Media Contacts:

Shana Jalbert                                                                    
Marketing Director                                                        
Greenphire
215.948.9260
[email protected]                                                                               

SOURCE Greenphire